Neurocrine biosciences to participate at virtual investor conferences in march

Ubs virtual cns day 2024 conference on march 18 stifel 2024 virtual cns days conference on march 19 san diego, march 11, 2024 /prnewswire/ -- neurocrine biosciences, inc. (nasdaq: nbix) will participate at two upcoming virtual investor conferences in march. eiry roberts, chief medical officer, and kyle gano, chief business development and strategy officer, will present at the ubs virtual cns day conference at 12:00 p.m.
NBIX Ratings Summary
NBIX Quant Ranking